-
-
-
-
-
-
-
THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points
-
-
-
-
-
-
-
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
-
-
-
-
-
-
-
Oncolytics Biotech (ONCY) Appoints Andrew Aromando as Chief Business Officer
-
-
-
-
-
-
-
Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders and Appoints James T. Parsons to its Board of Directors
-
-
-
-
-
-
-
Oncolytics Biotech (ONCY) Names Leonard Kruimer to Board
-
1,158,568 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

